PRSS21 and metastatic neoplasm: Although its role in CC is unexplored, PRSS21 is known to inhibit primary ovarian tumor metastasis by antagonizing proangiogenic proteins.22 Interestingly, PRSS21 was under-expressed in Black patients with localized or regional disease but overexpressed in those with metastatic disease.